Handelsavisen
prelaunch
Companies Healthcare NHL.CM
NH
NHL.CM Healthcare Facilities & Services

Nawaloka Hospitals PLC

$15,70
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
9,2 %
ROE
1,1 %
Net margin
0,5 %
Debt / equity
1,58
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Nawaloka Hospitals PLC operates as a provider of healthcare services in Sri Lanka, generating revenue primarily through hospital operations and outpatient services.

Business. Nawaloka Hospitals PLC (NHL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker NHL.CM. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
1,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning NHL.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to NHL.CM. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Nawaloka Hospitals PLC (NHL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker NHL.CM. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    Nawaloka Hospitals PLC has a debt-to-equity ratio of 1.58, indicating a relatively high level of leverage, and a current ratio of 0.32, suggesting limited short-term liquidity. The company's free cash flow of 541.7 million LKR supports operational flexibility, but its operating cash flow of 1.13 billion LKR is partially offset by capital expenditures of -340.7 million LKR.

    The company's return on equity (ROE) is 1.15%, and return on assets (ROA) is 0.28%, both of which are below the typical performance benchmarks for the healthcare sector, indicating suboptimal capital efficiency. These metrics suggest that the company is not generating strong returns relative to its equity and asset base.

    Nawaloka Hospitals PLC's revenue is concentrated in Sri Lanka, with no disclosed international operations. The company's business is primarily driven by domestic healthcare demand, and there is no indication of diversified geographic exposure. This concentration increases vulnerability to local economic and regulatory shifts.

    The company's growth trajectory is modest, with no disclosed revenue growth rates or future projections. Historical revenue of 11.01 billion LKR reflects stable operations but lacks evidence of significant expansion. The absence of clear growth drivers or strategic initiatives limits visibility into future performance.

    The company faces medium liquidity risk due to its current ratio of 0.32 and a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no recent or disclosed share issuance activity. However, the high debt-to-equity ratio of 1.58 suggests potential refinancing risks in the medium term.

    No recent events, such as filings or transcripts, have been disclosed in the available data. The company's financial and operational updates are limited to standard financial reporting, with no material developments reported in the latest available documents.

    Key takeaways
    • Nawaloka Hospitals PLC has a high debt-to-equity ratio of 1.58, indicating significant leverage.
    • The company's ROE of 1.15% and ROA of 0.28% are below typical healthcare sector benchmarks.
    • Revenue is concentrated in Sri Lanka, with no international diversification.
    • Free cash flow of 541.7 million LKR supports operations, but capital expenditures are a drag.
    • Liquidity risk is medium, and dilution risk is low based on current financials.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $15,70
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $4.91B
    Net cash
    -$7.43B
    Current ratio
    0.3
    Debt / equity
    1.6
    ROA
    0.3%
    ROE
    1.1%
    Cash conversion
    2010.0%
    CapEx / revenue
    -3.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin9,2 %Above median
    Net Margin0,5 %Below median
    ROE1,1 %Below median
    Capex / Rev-3,1 %Above P75
    D/E1,58Bottom quartile
    Cash Conv20,10Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Nawaloka Hospitals PLC Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    NHL.CMCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage